![](/img/cover-not-exists.png)
The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-γ–producing cells
Brugnolo, Francesca, Sampognaro, Salvatore, Liotta, Francesco, Cosmi, Lorenzo, Annunziato, Francesco, Manuelli, Cinzia, Campi, Paolo, Maggi, Enrico, Romagnani, Sergio, Parronchi, PaolaVolume:
111
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1067/mai.2003.102
Date:
February, 2003
File:
PDF, 253 KB
english, 2003